About this trial
The purpose of this study is to investigate the effects of a 12-week flexi band resistance training program compared to different whole-body electromyostimulation (WB-EMS) exercise programs on muscle strength, body composition (in particular muscle mass), cardiorespiratory fitness, inflammation, and patient-reported subjective outcomes (e.g. quality of life, fatigue, performance status) in patients with malignant disease undergoing curative or palliative anti-cancer treatment.
Eligibility criteria
Qualifiers
malignant disease (solid or hematological cancer): head and neck cancer, colorectal carcinoma, small intestinal cancer, gastric cancer, oesophageal cancer, pancreas carcinoma, liver cell carcinoma, cholangiocarcinoma, lung cancer, breast cancer, cervix cancer, ovarian cancer, prostate cancer, renal cell carcinoma, malignant melanoma, patients with leukaemia and malignant lymphomas or Graft-versus-Host-Disease after bone marrow transplantation
ongoing or planned curative or palliative anti-cancer therapy
ECOG-Status 0-2
Disqualifiers
simultaneous participation in other nutritional or exercise intervention Trials
bone metastases with high fracture risk
cardiovascular disease
use of anabolic medications
Trial design
Treatments tested in this trial
- WB-EMS (Sham-intervention)
- WB-EMS
- Free WB-EMS
- Flexi band resistance training